Overview

Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)

Status:
Completed
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the use of spirometry in identifying Diagnostic Error in COPD and Asthma patients.
Phase:
Phase 3
Details
Lead Sponsor:
University of Illinois at Chicago
Collaborator:
Agency for Healthcare Research and Quality (AHRQ)
Treatments:
Albuterol